Insider holders · CIK 0000910267
TITAN PHARMACEUTICALS INC · TTNP
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Federico Seghi RecliDirector | 800,845 | — | 800,845 | Oct 22, 2018 · 4:38 pm EDT | Form 4 |
| Marc RubinExecutive Chairman | 556,317 | — | 556,317 | Sep 25, 2018 · 7:02 pm EDT | Form 4 |
| Sunil BhonsleSee Remarks | 435,578 | 54,684 | 490,262 | Sep 25, 2018 · 7:06 pm EDT | Form 4 |
| James R McNabDirector | 300,000 | 100,000 | 400,000 | Sep 25, 2018 · 7:04 pm EDT | Form 4 |
| Joseph A AkersDirector | 213,000 | — | 213,000 | Sep 25, 2018 · 7:00 pm EDT | Form 4 |
| M David MacfarlaneDirector | 102,275 | — | 102,275 | Sep 25, 2018 · 7:09 pm EDT | Form 4 |
| Katherine BeebeChief Scientific Officer | 2,387 | — | 2,387 | Feb 25, 2019 · 5:36 pm EST | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.